Bioxyne Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other companies in this sector in AUSTRALIA : Proteomics International Laboratories Ltd (2019 sales of 1.52 million Australian Dollars [US$1.06 million] ), Starpharma Holdings Limited (2.72 million Australian Dollars [US$1.90 million] of which 100% was Dendritic), and Factor Therapeutics Ltd (2.49 million Australian Dollars [US$1.74 million] of which 100% was Biotechnology).

Sales Analysis. During the year ended June of 2019, sales at Bioxyne Limited were A$2.13 million (US$1.49 million). This is an increase of 7.1% versus 2018, when the company's sales were A$1.99 million. The sales level in 2019 was fairly close to the level five years ago: in 2014, Bioxyne Limited had sales of A$2.31 million.